Edgewise Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EWTX and other ETFs, options, and stocks.

About EWTX

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need.

CEO

Kevin Koch

CEOKevin Koch

Employees

110

Employees110

Headquarters

Boulder, Colorado

HeadquartersBoulder, Colorado

Founded

2017

Founded2017

Employees

110

Employees110

EWTX Key Statistics

Market cap

1.59B

Market cap1.59B

Price-Earnings ratio

-10.32

Price-Earnings ratio-10.32

Dividend yield

—

Dividend yield—

Average volume

963.61K

Average volume963.61K

High today

$16.06

High today$16.06

Low today

$14.67

Low today$14.67

Open price

$16.06

Open price$16.06

Volume

745.98K

Volume745.98K

52 Week high

$38.12

52 Week high$38.12

52 Week low

$10.60

52 Week low$10.60

Analyst ratings

77%

of 13 ratings

Buy

76.9%

Hold

23.1%

Sell

People also own

Based on the portfolios of people who own EWTX. This list is generated using Robinhood data, and it’s not a recommendation.